Related references
Note: Only part of the references are listed.Physiological role and clinical utility of inositols in polycystic ovary syndrome
Arturo Bevilacqua et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2016)
Inositol induces mesenchymal-epithelial reversion in breast cancer cells through cytoskeleton rearrangement
Simona Dinicola et al.
EXPERIMENTAL CELL RESEARCH (2016)
Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease
Mariano Bizzarri et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway
Tomoyuki Koguchi et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Cancer prevention and therapy through the modulation of transcription factors by bioactive natural compounds
Muthu K. Shanmugam et al.
SEMINARS IN CANCER BIOLOGY (2016)
The Inositol Polyphosphate 5-Phosphatase PIPP Regulates AKT1-Dependent Breast Cancer Growth and Metastasis
Lisa M. Ooms et al.
CANCER CELL (2015)
Reflections on inositol(s) for PCOS therapy: steps toward success
John E. Nestler et al.
GYNECOLOGICAL ENDOCRINOLOGY (2015)
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women
Rosario D'Anna et al.
OBSTETRICS AND GYNECOLOGY (2015)
Conundrum of IP6
Ivana Vucenik
OPEN BIOLOGY (2015)
A novel method for the purification of inositol phosphates from biological samples reveals that no phytate is present in human plasma or urine
Miranda S. C. Wilson et al.
OPEN BIOLOGY (2015)
One hundred years of somatic mutation theory of carcinogenesis: Is it time to switch?
Ana M. Soto et al.
BIOESSAYS (2014)
Improvement of mouse embryo quality by myo-inositol supplementation of IVF media
Sandra Colazingari et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2014)
A Bacterial Homolog of a Eukaryotic Inositol Phosphate Signaling Enzyme Mediates Cross-kingdom Dialog in the Mammalian Gut
Regis Stentz et al.
CELL REPORTS (2014)
Tumor and the Microenvironment: A Chance to Reframe the Paradigm of Carcinogenesis?
Mariano Bizzarri et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Effects of myo-inositol on proliferation, differentiation, oxidative status and antioxidant capacity of carp enterocytes in primary culture
W. -D. Jiang et al.
AQUACULTURE NUTRITION (2013)
Tumour cells can employ extracellular Ins(1,2,3,4,5,6)P6 and multiple inositol-polyphosphate phosphatase 1 (MINPP1) dephosphorylation to improve their proliferation
Sabine Windhorst et al.
BIOCHEMICAL JOURNAL (2013)
Potential role and therapeutic interests of myo-inositol in metabolic diseases
Marine L. Croze et al.
BIOCHIMIE (2013)
Insulin resistance and cancer: the role of insulin and IGFs
Sefirin Djiogue et al.
ENDOCRINE-RELATED CANCER (2013)
Pro-Apoptotic Effect of Rice Bran Inositol Hexaphosphate (IP6) on HT-29 Colorectal Cancer Cells
Nurul Husna Shafie et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Theoretical aspects of Systems Biology
Mariano Bizzarri et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2013)
Preventive Inositol Hexaphosphate Extracted from Rice Bran Inhibits Colorectal Cancer through Involvement of Wnt/β-Catenin and COX-2 Pathways
Nurul Husna Shafie et al.
BIOMED RESEARCH INTERNATIONAL (2013)
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome
A. Santamaria et al.
CLIMACTERIC (2012)
Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome
Gabriella Dona et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Myo-inositol soft gel capsules may prevent the risk of coffee-induced neural tube defects
Sara De Grazia et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Metabolism and Regulation of Glycerolipids in the Yeast Saccharomyces cerevisiae
Susan A. Henry et al.
GENETICS (2012)
Wnt Signaling in Cancer
Paul Polakis
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Heavy metals and living systems: An overview
Reena Singh et al.
INDIAN JOURNAL OF PHARMACOLOGY (2011)
Pharmacokinetics and tissue distribution of inositol hexaphosphate in C.B17 SCID mice bearing human breast cancer xenografts
Julie Eiseman et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Inositol Pyrophosphates as Mammalian Cell Signals
Anutosh Chakraborty et al.
SCIENCE SIGNALING (2011)
Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice
Fekadu Kassie et al.
CARCINOGENESIS (2010)
Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination
Fekadu Kassie et al.
CARCINOGENESIS (2010)
Inositol Pyrophosphates Inhibit Akt Signaling, Thereby Regulating Insulin Sensitivity and Weight Gain
Anutosh Chakraborty et al.
CELL (2010)
Interruption of Inositol Sphingolipid Synthesis Triggers Stt4p-dependent Protein Kinase C Signaling
Stephen A. Jesch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Efficacy of IP6 + inositol in the treatment of breast cancer patients receiving chemotherapy: prospective, randomized, pilot clinical study
Ivan Bacic et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Airway PI3K Pathway Activation Is an Early and Reversible Event in Lung Cancer Development
Adam M. Gustafson et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The Chemopreventive Agent Myoinositol Inhibits Akt and Extracellular Signal-Regulated Kinase in Bronchial Lesions from Heavy Smokers
Wei Han et al.
CANCER PREVENTION RESEARCH (2009)
p21/Cip1 and p27/Kip1 Are Essential Molecular Targets of Inositol Hexaphosphate for Its Antitumor Efficacy against Prostate Cancer
Srirupa Roy et al.
CANCER RESEARCH (2009)
Inositol Hexaphosphate Suppresses Growth and Induces Apoptosis in Prostate Carcinoma Cells in Culture and Nude Mouse Xenograft: PI3K-Akt Pathway as Potential Target
Mallikarjuna Gu et al.
CANCER RESEARCH (2009)
The biological activity of structurally defined inositol glycans
Meenakshi Goel et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Transforming growth factor β signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures
A. Di Sabatino et al.
GUT (2009)
Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors
Yoshiyuki Hattori et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors
J-S Diallo et al.
BRITISH JOURNAL OF CANCER (2008)
Chernopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice
Komal Raina et al.
CLINICAL CANCER RESEARCH (2008)
Neoplasia as development gone awry: the role of endocrine disruptors
Ana M. Soto et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2008)
Phytate: impact on environment and human nutrition. A challenge for molecular breeding
Lisbeth Bohn et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2008)
Response to Demonizing phytate
NATURE BIOTECHNOLOGY (2008)
Demonizing phytate
AlmlKalam M. Shamsuddin
NATURE BIOTECHNOLOGY (2008)
Evidence for an inositol hexakisphosphate-dependent role for Ku in mammalian nonhomologous end joining that is independent of its role in the DNA-dependent protein kinase
Joyce C. Y. Cheung et al.
NUCLEIC ACIDS RESEARCH (2008)
Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells
Surajit Karmakar et al.
NEUROCHEMICAL RESEARCH (2007)
Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds
Jie Liao et al.
CARCINOGENESIS (2007)
Inositol hexaphosphate: A potential chelating agent for uranium
D. Cebrian et al.
RADIATION PROTECTION DOSIMETRY (2007)
Phytic acid modulates in vitro IL-8 and IL-6 release from colonic epithelial cells stimulated with LPS and IL-1 beta
Ludmila Weglarz et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Inositol hexaphosphate represses telomerase activity and translocates TERT from the nucleus in mouse and human prostate cancer cells via the deactivation of Akt and PKCα
Shankar Jagadeesh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A phase I study of myo-inositol for lung cancer chernoprevention
Stephen Lam et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Inositol hexaphosphate (IP6) inhibits cellular proliferation in melanoma
Irfan Rizvi et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide
NRF Nascimento et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Protection against cancer by dietary IP6 and inositol
Ivana Vucenik et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2006)
Prognostic value of activated Akt expression in oral squamous cell carcinoma
J Lim et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects
T Maffucci et al.
CANCER RESEARCH (2005)
Inositol hexaphosphate-induced enhancement of natural killer cell activity correlates with suppression of colon carcinogenesis in rats
Zheng Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCδ-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation
I Vucenik et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast
SA Jesch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
PI3K/Akt signalling pathway and cancer
JAF Vara et al.
CANCER TREATMENT REVIEWS (2004)
Inhibition of xanthine oxidase by phytic acid and its antioxidative action
S Muraoka et al.
LIFE SCIENCES (2004)
Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells
C Agarwal et al.
NEOPLASIA (2004)
Wnt/β-catenin signaling pathway as novel cancer drug targets
HH Luu et al.
CURRENT CANCER DRUG TARGETS (2004)
Role of the unfolded protein response pathway in secretory stress and regulation of INO1 expression in Saccharomyces cerevisiae
HJ Chang et al.
GENETICS (2004)
Anti-angiogenic activity of inositol hexaphosphate (IP6)
I Vucenik et al.
CARCINOGENESIS (2004)
In vivo suppression of hormone-refractory prostate cancer growth by inositol hexaphosphate: Induction of insulin-like growth factor binding protein-3 and inhibition of vascular endothelial growth factor
RP Singh et al.
CLINICAL CANCER RESEARCH (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
Visualization of inositol phosphate-dependent mobility of Ku:: depletion of the DNA-PK cofactor InsP6 inhibits Ku mobility
J Byrum et al.
NUCLEIC ACIDS RESEARCH (2004)
Genome expression analysis in yeast reveals novel transcriptional regulation by inositol and choline and new regulatory functions for Opi1p, Ino2p, and Ino4p
TC Santiago et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Inositol hexaphosphate (IP6) enhances the anti-proliferative effects of adriamycin and tamoxifen in breast cancer
K Tantivejkul et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme
U Peters et al.
LANCET (2003)
Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes
RP Singh et al.
CARCINOGENESIS (2003)
Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates
XT Shen et al.
SCIENCE (2003)
Regulation of chromatin remodeling by inositol polyphosphates
DJ Steger et al.
SCIENCE (2003)
Regulation of inositol phospholipid binding and signaling through syndecan-4
JR Couchman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NFκB-mediated cell survival pathway
S Ferry et al.
CARCINOGENESIS (2002)
Inhibition of lung tumorigenesis in A/J mice by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-L-cysteine and myo-inositol, individually and in combination
SS Hecht et al.
CARCINOGENESIS (2002)
Effects of exogenous inositol hexakisphosphate (InsP6) on the levels of InsP6 and of inositol trisphosphate (InsP3) in malignant cells, tissues and biological fluids
F Grases et al.
LIFE SCIENCES (2002)
Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance
SK Fisher et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Effect of inositol hexaphosphate (IP6) on human normal and leukaemic haematopoietic cells
GL Deliliers et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Protective effect of phytic acid on oxidative DNA damage with reference to cancer chemoprevention
K Midorikawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Inhibition of acetyl coenzyme a carboxylase activity restores expression of the INO1 gene in a snf1 mutant strain of Saccharomyces cerevisiae
MK Shirra et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells
XL Zi et al.
CARCINOGENESIS (2000)
Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair
LA Hanakahi et al.
CELL (2000)
Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis
M Jenab et al.
CARCINOGENESIS (2000)
Inositol polyphosphate multikinase (ArgRIII) determines nuclear mRNA export in Saccharomyces cerevisiae
A Saiardi et al.
FEBS LETTERS (2000)
5 ' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells
V Taylor et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
